阿斯利康投资40亿美元扩建美国医药中心

DoNews
Jul 22, 2025

2025年7月22日,阿斯利康(AZN.LN)宣布将投资40亿美元用于扩建位于美国弗吉尼亚州的医药生产中心。此次投资旨在提升公司在北美市场的药品生产能力,并加速创新药物的全球供应。尽管消息公布后市场反应平稳,阿斯利康ADR美股盘后微跌0.03%。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10